Clinical Trial Update: Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports efficacy and safety results for T2762 and Vismed® in Dry Eye Syndrome, sponsored by Laboratoires Thea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• T2762
• Vismed

Snippet

Sponsor: Laboratoires Thea | Conditions: Dry Eye Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2016-04-06